BARCLAYS PLC

Position in IMTX — Immatics N.V.

CIK 312069 LONDON, X0

Position in IMTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$636,195

+$340,253 QoQ

Shares Held

64,654

+129.4% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,004,783 across 361 Biotechnology names. IMTX ranks #134 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$636,195	64,654	+129.4%	Shares	Defined	2026-05-15
2025-12-31	$295,942	28,185	+11.4%	Shares	Sole	2026-02-13
2025-09-30	$215,649	25,311	0.0%	Shares	Sole	2026-03-31
2025-06-30	$136,173	25,311	0.0%	Shares	Sole	2026-02-27
2025-03-31	$114,152	25,311	+3161.7%	Shares	Sole	2026-03-17
2024-12-31	$5,517	776	-45.9%	Shares	Sole	2026-03-19
2024-09-30	$16,361	1,434	0.0%	Shares	Sole	2026-03-31
2024-06-30	$16,663	1,434	-8.1%	Shares	Sole	2026-03-23
2024-03-31	$16,395	1,560	-8.0%	Shares	Sole	2026-03-24
2023-12-31	$17,858	1,696	-1.2%	Shares	Sole	2026-03-24
2023-09-30	$19,871	1,716	+179.9%	Shares	Sole	2026-03-26
2023-06-30	$7,074	613	-75.5%	Shares	Sole	2026-03-27
2023-03-31	$17,250	2,500	—	Shares	Sole	2026-03-30
No filing history on record for this holder in this stock.